Nagla A. Karim, Hai Bui, Peterson Pathrose, Sandra Starnes, Ninad Patil, Mahmoud Shehata, Ahmed Mostafa, MB Rao, Ahmad Zarzour and Marshall Anderson, Author at Cancer Therapy Advisor

Nagla A. Karim, Hai Bui, Peterson Pathrose, Sandra Starnes, Ninad Patil, Mahmoud Shehata, Ahmed Mostafa, MB Rao, Ahmad Zarzour and Marshall Anderson

All articles by Nagla A. Karim, Hai Bui, Peterson Pathrose, Sandra Starnes, Ninad Patil, Mahmoud Shehata, Ahmed Mostafa, MB Rao, Ahmad Zarzour and Marshall Anderson

Clinical Medicine Insights: Oncology

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

[Clinical Medicine Insights: Oncology] Performance status is the only known clinical predictor of outcome in patients with advanced non-small-cell lung cancer (NSCLC), but pharmacogenomic markers may also correlate with outcome. This study attempts to correlate clinical and pharmacogenomic measures with overall survival.

Next post in Lung Cancer